Fujian Medical University Union Hospital
Fuzhou, Fujian, 350000, China
Location status: Recruiting
NCT Number: NCT05524922
Cognitive impairment often appears in neurodegenerative diseases, and it is expected to further study the mechanism of sleep disorders associated with the progression of neurodegenerative diseases by exploring the clinical manifestations, imaging, and biological marker changes of sleep disorders in neurodegenerative diseases.
Interested in participating?
Request Info30 year–80 year
All sexes
Observational
Fuzhou, Fujian, 350000, China
Location status: Recruiting
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Neuropsychological assessment, brain MRI, electroencephalogram and biomarker datas will be collected
Time frame: Baseline
Pittsburgh Sleep Quality Index (PSQI),
Time frame: Baseline
The Montreal Cognitive Assessment (MoCA)
Time frame: Baseline
Addenbrooke's Cognitive Examination (ACE) score
Time frame: Baseline
Heart rate variability (HRV) was calculated as the maximum bpm - minimum bpm.
Time frame: Baseline
Time frame: Baseline
The intra-cellular compartment (Vic) of the Neurite Orientation Dispersion and Density Imaging (NODDI) model represents diffusion within the axons and cells.
Time frame: Baseline
The alpha-peak frequency (PAF) is the frequency with the highest power within the alpha-band.
Time frame: 1 year after baseline
The intra-cellular compartment (Vic) of the Neurite Orientation Dispersion and Density Imaging (NODDI) model represents diffusion within the axons and cells.
Contact information is provided by the study sponsor or research team.
Fujian Medical University Union Hospital
Other
A Registered Observational Cohort Study on Neurodegenerative Associated With Sleep Disorder.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04477785
Anosmia, Basal Ganglia Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT07598370
Alzheimer Disease, Brain Diseases
Irvine, California, United States
View Trial DetailsNCT05357612
Basal Ganglia Diseases, Brain Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT07589595
Alzheimer Disease, Amyloid
Chandler, Arizona, United States
View Trial Details